Clinical Efficacy of Soluble Thrombomodulin, Tissue Plasminogen Activator Inhibitor complex, Thrombin-Antithrombin complex,α2-Plasmininhibitor-Plasmin complex in Pediatric Sepsis
Objective To investigated the clinical efficacy of Soluble thrombomodulin (sTM), tissue plasminogen activator inhibitor complex (t-PAI·C),thrombin-antithrombin complex (TAT),α2-plasmininhibitor-plasmin complex (PIC) in pediatric sepsis and pediatrics sepsis-induced coagulopathy (pSIC). Methods We pr...
Main Authors: | Juanzhen Li, Jingyi Zhou, Hong Ren, Teng Teng, Biru Li, Ying Wang, Long Xiang |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2022-05-01
|
Series: | Clinical and Applied Thrombosis/Hemostasis |
Online Access: | https://doi.org/10.1177/10760296221102929 |
Similar Items
-
Sepsis-Associated DIC with Decreased Levels of Antithrombin and Fibrinogen is the Target for Combination Therapy with Thrombomodulin Alfa and Antithrombin
by: Hideo Wada, et al.
Published: (2023-01-01) -
Thrombin antithrombin complex and IL-18 serum levels in stroke patients
by: Ornella Piazza, et al.
Published: (2010-02-01) -
Age-related differences in the survival benefit of the administration of antithrombin, recombinant human thrombomodulin, or their combination in sepsis
by: Takeshi Wada, et al.
Published: (2022-06-01) -
Effect of plasma thrombin-antithrombin complex on ischemic stroke: a systematic review and meta-analysis
by: Peipei Song, et al.
Published: (2023-02-01) -
Plasmin and plasminogen prevent sepsis severity by reducing neutrophil extracellular traps and systemic inflammation
by: Juliana P. Vago, et al.
Published: (2023-04-01)